PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $356,000 | +21.1% | 68,940 | -10.1% | 0.00% | – |
| Q2 2021 | $294,000 | +40.7% | 76,683 | -5.9% | 0.00% | – |
| Q1 2021 | $209,000 | -7.9% | 81,471 | -10.5% | 0.00% | – |
| Q4 2020 | $227,000 | +39.3% | 90,995 | +15.2% | 0.00% | – |
| Q3 2020 | $163,000 | -35.6% | 78,967 | -3.3% | 0.00% | – |
| Q2 2020 | $253,000 | +44.6% | 81,702 | +6.5% | 0.00% | – |
| Q1 2020 | $175,000 | +173.4% | 76,741 | +304.1% | 0.00% | – |
| Q3 2019 | $64,000 | +52.4% | 18,989 | +49.5% | 0.00% | – |
| Q1 2019 | $42,000 | -39.1% | 12,701 | -7.2% | 0.00% | – |
| Q2 2018 | $69,000 | -34.9% | 13,687 | -12.2% | 0.00% | – |
| Q1 2018 | $106,000 | +37.7% | 15,585 | +53.1% | 0.00% | – |
| Q4 2017 | $77,000 | -42.1% | 10,181 | -56.0% | 0.00% | – |
| Q3 2017 | $133,000 | +146.3% | 23,140 | +120.5% | 0.00% | – |
| Q2 2017 | $54,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $1,779,205 | 0.70% |
| 1620 INVESTMENT ADVISORS, INC. | 4,421 | $317,605 | 0.35% |
| CM Management, LLC | 750,000 | $136,500 | 0.11% |
| BVF INC/IL | 20,609,863 | $3,750,995 | 0.09% |
| NorthStar Asset Management LLC /NJ/ | 39,065 | $7,110 | 0.01% |
| XTX Topco Ltd | 39,689 | $7,223 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $5,460 | 0.00% |
| Virtu Financial LLC | 90,059 | $16 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $174 | 0.00% |
| OSAIC HOLDINGS, INC. | 516 | $94 | 0.00% |